AIRLINK 73.00 Decreased By ▼ -1.10 (-1.48%)
BOP 5.02 Increased By ▲ 0.02 (0.4%)
CNERGY 4.32 Decreased By ▼ -0.02 (-0.46%)
DFML 29.10 Decreased By ▼ -0.44 (-1.49%)
DGKC 82.15 Decreased By ▼ -1.40 (-1.68%)
FCCL 22.08 Decreased By ▼ -0.35 (-1.56%)
FFBL 34.30 Decreased By ▼ -0.60 (-1.72%)
FFL 9.94 Increased By ▲ 0.07 (0.71%)
GGL 10.03 Increased By ▲ 0.03 (0.3%)
HBL 111.59 Decreased By ▼ -0.41 (-0.37%)
HUBC 138.00 Increased By ▲ 0.31 (0.23%)
HUMNL 7.15 Increased By ▲ 0.17 (2.44%)
KEL 4.38 Decreased By ▼ -0.02 (-0.45%)
KOSM 4.57 Decreased By ▼ -0.02 (-0.44%)
MLCF 38.10 Decreased By ▼ -0.45 (-1.17%)
OGDC 134.80 Decreased By ▼ -1.80 (-1.32%)
PAEL 26.20 Increased By ▲ 1.06 (4.22%)
PIAA 26.60 Increased By ▲ 0.09 (0.34%)
PIBTL 6.66 Increased By ▲ 0.01 (0.15%)
PPL 123.50 Decreased By ▼ -1.90 (-1.52%)
PRL 27.90 Decreased By ▼ -0.31 (-1.1%)
PTC 13.85 Decreased By ▼ -0.45 (-3.15%)
SEARL 53.76 Decreased By ▼ -0.84 (-1.54%)
SNGP 70.15 Decreased By ▼ -1.05 (-1.47%)
SSGC 10.58 Increased By ▲ 0.08 (0.76%)
TELE 8.49 Decreased By ▼ -0.03 (-0.35%)
TPLP 10.90 Decreased By ▼ -0.04 (-0.37%)
TRG 60.11 Decreased By ▼ -0.59 (-0.97%)
UNITY 25.22 Decreased By ▼ -0.11 (-0.43%)
WTL 1.26 No Change ▼ 0.00 (0%)
BR100 7,639 Decreased By -25.7 (-0.34%)
BR30 24,885 Decreased By -140.1 (-0.56%)
KSE100 72,867 Increased By 102.3 (0.14%)
KSE30 23,700 Decreased By -75.8 (-0.32%)
World

EU exec OK for Moderna vaccine to come shortly

  • With EMA approval of the Moderna vaccine, we are closer to our goal of having a portfolio of safe and effective COVID-19 vaccines.
Published January 6, 2021

BRUSSELS: The European Commission will shortly approve for use the COVID-19 vaccine developed by US company Moderna, the bloc's top health official said after the European Medicines Agency (EMA) approved the drug on Wednesday.

"With EMA approval of the Moderna vaccine, we are closer to our goal of having a portfolio of safe and effective COVID-19 vaccines. EU Commission authorisation will follow shortly," EU health Commissioner Stella Kyriakides said in a tweet.

Comments

Comments are closed.